These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 25898205)
1. The influence of artificially introduced N-glycosylation sites on the in vitro activity of Xenopus laevis erythropoietin. Nagasawa K; Meguro M; Sato K; Tanizaki Y; Nogawa-Kosaka N; Kato T PLoS One; 2015; 10(4):e0124676. PubMed ID: 25898205 [TBL] [Abstract][Full Text] [Related]
2. Structural and biological properties of erythropoietin in Xenopus laevis. Nogawa-Kosaka N; Hirose T; Kosaka N; Aizawa Y; Nagasawa K; Uehara N; Miyazaki H; Komatsu N; Kato T Exp Hematol; 2010 May; 38(5):363-72. PubMed ID: 20193733 [TBL] [Abstract][Full Text] [Related]
3. N-glycosylation-defective receptor for erythropoietin can transduce the ligand-induced cell proliferation signal. Nagao M; Morishita E; Hanai Y; Kobayashi K; Sasaki R FEBS Lett; 1995 Oct; 373(3):225-8. PubMed ID: 7589471 [TBL] [Abstract][Full Text] [Related]
4. Quantification and localization of erythropoietin-receptor-expressing cells in the liver of Xenopus laevis. Okui T; Yamamoto Y; Maekawa S; Nagasawa K; Yonezuka Y; Aizawa Y; Kato T Cell Tissue Res; 2013 Jul; 353(1):153-64. PubMed ID: 23640133 [TBL] [Abstract][Full Text] [Related]
5. Glycosylation of erythropoietin affects receptor binding kinetics: role of electrostatic interactions. Darling RJ; Kuchibhotla U; Glaesner W; Micanovic R; Witcher DR; Beals JM Biochemistry; 2002 Dec; 41(49):14524-31. PubMed ID: 12463751 [TBL] [Abstract][Full Text] [Related]
6. Erythropoietin and co.: intrinsic structure and functional disorder. Uversky VN; Redwan EM Mol Biosyst; 2016 Dec; 13(1):56-72. PubMed ID: 27833947 [TBL] [Abstract][Full Text] [Related]
7. Control of rHuEPO biological activity: the role of carbohydrate. Elliott S; Egrie J; Browne J; Lorenzini T; Busse L; Rogers N; Ponting I Exp Hematol; 2004 Dec; 32(12):1146-55. PubMed ID: 15588939 [TBL] [Abstract][Full Text] [Related]
8. Effects of site-directed removal of N-glycosylation sites in human erythropoietin on its production and biological properties. Yamaguchi K; Akai K; Kawanishi G; Ueda M; Masuda S; Sasaki R J Biol Chem; 1991 Oct; 266(30):20434-9. PubMed ID: 1657925 [TBL] [Abstract][Full Text] [Related]
9. Characterization of three erythropoietin (Epo)-binding proteins in various human Epo-responsive cell lines and in cells transfected with human Epo-receptor cDNA. Takahashi T; Chiba S; Hirano N; Yazaki Y; Hirai H Blood; 1995 Jan; 85(1):106-14. PubMed ID: 7803787 [TBL] [Abstract][Full Text] [Related]
10. Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family. Middleton SA; Johnson DL; Jin R; McMahon FJ; Collins A; Tullai J; Gruninger RH; Jolliffe LK; Mulcahy LS J Biol Chem; 1996 Jun; 271(24):14045-54. PubMed ID: 8662939 [TBL] [Abstract][Full Text] [Related]
11. The importance of N- and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Wasley LC; Timony G; Murtha P; Stoudemire J; Dorner AJ; Caro J; Krieger M; Kaufman RJ Blood; 1991 Jun; 77(12):2624-32. PubMed ID: 2043765 [TBL] [Abstract][Full Text] [Related]
12. Subunit structure of the erythropoietin receptor analyzed by 125I-Epo cross-linking in cells expressing wild-type or mutant receptors. Miura O; Ihle JN Blood; 1993 Apr; 81(7):1739-44. PubMed ID: 8461460 [TBL] [Abstract][Full Text] [Related]
13. Expression of erythropoietin receptor-like molecule in Xenopus laevis and erythrocytopenia upon administration of its recombinant soluble form. Aizawa Y; Nogawa N; Kosaka N; Maeda Y; Watanabe T; Miyazaki H; Kato T J Biochem; 2005 Aug; 138(2):167-75. PubMed ID: 16091591 [TBL] [Abstract][Full Text] [Related]
14. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function. Schimmenti LA; Blechert G; Harris KW; Winkelmann JC Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361 [TBL] [Abstract][Full Text] [Related]
16. N- and O-glycosylation muteins of recombinant human erythropoietin secreted from BHK-21 cells. Fibi MR; Hermentin P; Pauly JU; Lauffer L; Zettlmeissl G Blood; 1995 Mar; 85(5):1229-36. PubMed ID: 7858253 [TBL] [Abstract][Full Text] [Related]
17. Functional conservation of erythropoietin signaling in zebrafish. Paffett-Lugassy N; Hsia N; Fraenkel PG; Paw B; Leshinsky I; Barut B; Bahary N; Caro J; Handin R; Zon LI Blood; 2007 Oct; 110(7):2718-26. PubMed ID: 17579187 [TBL] [Abstract][Full Text] [Related]
18. The functional form of the erythropoietin receptor is a 78-kDa protein: correlation with cell surface expression, endocytosis, and phosphorylation. Sawyer ST; Hankins WD Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6849-53. PubMed ID: 8341708 [TBL] [Abstract][Full Text] [Related]
19. Effect of tunicamycin treatment on ligand binding to the erythropoietin receptor: conversion from two classes of binding sites to a single class. Nagao M; Matsumoto S; Masuda S; Sasaki R Blood; 1993 May; 81(10):2503-10. PubMed ID: 8490167 [TBL] [Abstract][Full Text] [Related]
20. No erythropoietin-induced growth is observed in non-small cell lung cancer cells. Frille A; Leithner K; Olschewski A; Olschewski H; Wohlkönig C; Hrzenjak A Int J Oncol; 2018 Feb; 52(2):518-526. PubMed ID: 29345289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]